Immediate Impact
51 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
Neoantigens: promising targets for cancer therapy
2023 Standout
Works of Jay J. Liao being referenced
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck
2018
Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jay J. Liao | 415 | 426 | 317 | 95 | 1.1k | |
| Tony Y. Eng | 277 | 410 | 329 | 89 | 1.4k | |
| Merle M. Salter | 416 | 357 | 580 | 48 | 1.1k | |
| Evan Wuthrick | 349 | 482 | 238 | 57 | 995 | |
| Alexandra D Jensen | 682 | 362 | 553 | 70 | 1.4k | |
| É. Calitchi | 200 | 579 | 477 | 52 | 1.2k | |
| Smith Apisarnthanarax | 561 | 394 | 305 | 91 | 1.4k | |
| Shaakir Hasan | 545 | 457 | 361 | 118 | 1.2k | |
| Carl F. von Essen | 380 | 314 | 191 | 47 | 900 | |
| Kazuki Terashima | 755 | 298 | 325 | 71 | 1.3k | |
| Nikhil G. Rao | 524 | 505 | 154 | 49 | 985 |
All Works
Login with ORCID to disown or claim papers
Loading papers...